Your browser doesn't support javascript.
loading
Definition and Management of the Immune Tolerance Phase in Chronic Hepatitis B / 대한소화기학회지
The Korean Journal of Gastroenterology ; : 156-160, 2022.
Article in English | WPRIM | ID: wpr-926963
ABSTRACT
In the natural course of chronic hepatitis B, the immune tolerance phase is characterized by HBeAg positivity, very high levels of HBV DNA, and persistent normal alanine aminotransferase. The international guideline recommendation for patients in this phase is observation without antiviral treatment because of the low risk of disease progression and the lack of effective antiviral agents. However, recent retrospective studies have shown that progression to hepatic fibrosis and hepatocellular carcinoma may occur in patients who are in the immune tolerance phase. Despite the conceptual definition and clinical diagnostic criteria for this phase, it is difficult to accurately diagnose the true immune tolerance phase. Therefore, we should pay attention to the clinical evaluation and interpretation of the immune tolerance phase and understand the clinical situations in which antiviral treatments should be considered.
Full text: Available Index: WPRIM (Western Pacific) Type of study: Practice guideline / Observational study Language: English Journal: The Korean Journal of Gastroenterology Year: 2022 Type: Article

Similar

MEDLINE

...
LILACS

LIS

Full text: Available Index: WPRIM (Western Pacific) Type of study: Practice guideline / Observational study Language: English Journal: The Korean Journal of Gastroenterology Year: 2022 Type: Article